Critically Ill Patients Treated for Chimeric Antigen Receptor-Related Toxicity: A Multicenter Study*-Reference-Cited by-同舟云学术

Critically Ill Patients Treated for Chimeric Antigen Receptor-Related Toxicity: A Multicenter Study*

Published:2021-07-02 Issue:1 Volume:50 Page:81-92
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:

Author:

Gutierrez Cristina,Brown Anne Rain T.,May Heather P.,Beitinjaneh Amer,Stephens R. Scott,Rajendram Prabalini,Nates Joseph L.,Pastores Stephen M.,Dharshan Ananda,de Moraes Alice Gallo,Hensley Matthew K.,Feng Lei,Brudno Jennifer N.,Athale Janhavi,Ghosh Monalisa,Kochenderfer James N.,Arias Alejandro S.,Lin Yi,McEvoy Colleen,Mead Elena,Westin Jason,Kostelecky Natalie,Mian Agrima,Herr Megan M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference37 articles.

1. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): A multicentre seamless design study.;Abramson;Lancet,2020

2. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia.;Brentjens;Sci Transl Med,2013

3. Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.;Brudno;Nat Med,2020

4. T cells genetically modified to express an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of poor-prognosis relapsed multiple myeloma.;Brudno;J Clin Oncol,2018

5. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.;Davila;Sci Transl Med,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology and Outcomes of Hospitalized Chimeric Antigen Receptor T-Cell (CAR-T) Therapy Patients Who Developed Acute Respiratory Failure;Journal of Intensive Care Medicine;2024-05-09

2. Critical care utilisation for patients receiving chimeric antigen receptor (CAR) T cell therapy in the UK;British Journal of Anaesthesia;2024-05

3. An update on ICU outcomes in patients after CAR T therapy: A four-year tertiary UK centre experience;Journal of Critical Care;2024-04

4. Toxicities, intensive care management, and outcome of chimeric antigen receptor T cells in adults: an update;Critical Care;2024-03-05

5. Features and outcomes of patients admitted to the ICU for chimeric antigen receptor T cell-related toxicity: a French multicentre cohort;Annals of Intensive Care;2024-01-31